Martha regularly represents Chinese and international clients in cross-border M&A, private equity investments and financings, joint ventures, foreign direct investments and other compliance matters.
She has represented clients from a broad range of industries, including TMT, financial services, healthcare, consumer products, energy, manufacturing, etc.
In addition, she has experience in handling initial public offerings, debt and equity securities offerings, pre-IPO investments, as well as advising on restructuring, employment, antitrust, and general corporate matters.
Carol’s practice focuses on patent filing and prosecution, patent-related legal advice and patent litigation across a broad range of industries, including chemistry, materials science, pharmaceutical, biotechnology, medical device, semiconductor and auto mechanics. Carol has extensional experience in patent, trademark, domain name, copyright and trade secret.
Before joining Orrick, Carol worked with Lung Tin International Property Agent Ltd. and in Jones Day’s Beijing Office.
Being recognized by Legal 500 Asia Pacific, Jeff has received clients’ praises as “an experienced lawyer, who understands the client’s business, both internally and externally", and his "understanding of the client’s business model, industry, customers and strategic objectives enables him to advise and guide clients on highly complex and sensitive matters”. Other clients comment that Jeff “develops the best strategies and solutions for clients” and “works very hard and is recognised by clients for his ability.” In addition, he is “dedicated to serving his clients and is able to leverage off the firm’s global network to provide services in specialized areas.” (Legal 500 Asia-Pacific, 2019 - 2023)
Jeff’s practice focuses on China-related inbound and outbound mergers and acquisitions and private equity transactions. He has extensive experience with share and asset acquisitions, growth capital and buyout transactions as well as tender offers, privatizations, restructurings, spin-offs, strategic alliances and joint ventures.
In addition, Jeff advises multinationals, financial institutions and private equity funds on their general corporate, capital markets and regulatory compliance matters.
Prior to joining Orrick, Jeff was a partner at the New York office of an international law firm. Earlier in his career, Jeff practiced in New York, Hong Kong, and mainland China with two major international law firms, and also served as the Head of Legal and Compliance of the U.S. operations of a leading Chinese investment bank, where he gained tremendous experience in helping Chinese clients navigate regulatory and compliance issues in the U.S.
Jeff serves on the International Advisory Board of Duke Law School, where he was also appointed as a Senior Lecturing Fellow. In his leisure time, Jeff serves on a volunteer basis as the Chief Legal Officer of The Chinese Finance Association (TCFA), a non-profit professional organization headquartered in New York with more than 7,000 members globally.
Shelley's related IP experience includes the following:
Patent invalidation proceedings, anti-counterfeiting, anti-piracy efforts and patent and trademark enforcement litigation in China.
Prosecution of patent and trademark, including application preparation, office actions/oppositions procedures and reexamination procedures.
Enforcement and technology transfer/licensing arrangements for substantial patent and trademark portfolios for companies doing business in China.
Advising on IP protection strategies, R&D related IP issues and matters in relation to export and import control of technology.
Assisting Chinese companies in Section 337 U.S. International Trade Commission investigations, patent infringement litigations and product liability litigations in the U.S.
Jeffrey has extensive experience representing both Chinese enterprises in fund raising and investing abroad and foreign investors investing in China.
He regularly represents issuers and underwriters in the U.S. and Hong Kong public securities offerings, including initial public offerings (IPOs) and Rule 144A/Regulation S offerings for PRC-based companies.
In addition, he is experienced in handling complex cross-border mergers and acquisitions, foreign direct investment, strategic alliances, joint ventures and regulatory compliance matters for numerous foreign investors and Chinese companies. He also counsels global private equity funds on their investment activity throughout Greater China and across Asia.
Some clients he has represented include Bright Food, JD.com, Trina Solar, China Sunergy, Perfect World, ReneSola, Tudou, Pactera Technologies and some international investment banks and private equity funds.
Jeffrey is consistently recognized as a leading lawyer for China M&A by prestigious legal publications such as Chambers Asia, Asia-Pacific Legal 500 and IFLR1000. Clients recognizes him as “an excellent business partner, above his legal counsel role”, who “gives practical advice not only based on legal proficiency, but really helpful for our business”.
Prior to joining Orrick, Mr. Sun worked with a major international law firm, and he was a former partner in a local law firm based in Shanghai.
Please do not include any confidential, secret or otherwise sensitive information concerning any potential or actual legal matter in this e-mail message. Unsolicited e-mails do not create an attorney-client relationship and confidential or secret information included in such e-mails cannot be protected from disclosure. Orrick does not have a duty or a legal obligation to keep confidential any information that you provide to us. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.
By clicking "OK" below, you understand and agree that Orrick will have no duty to keep confidential any information you provide.